NVAX NOVAVAX INC Product Launches 8-K Filing 2023 - COVID-19 Vaccine Authorization Novavax announced that their COVID-19 vaccine has received Emergency Use Authorization from the FDA for individuals aged 12 and older.Get access to all SEC 8-K filings of the NOVAVAX INC